Literature DB >> 6159444

Role of accessory cells in B cell activation. III. Cellular analysis of primary immune response deficits in CBA/N mice: presence of an accessory cell-B cell interaction defect.

H S Boswell, M I Nerenberg, I Scher, A Singer.   

Abstract

The effect of the X-linked CBA/N genetic defect on the ability of mice to generate primary responses to thymic-dependent and thymic-independent antigens was assessed by comparing the ability of abnormal (CBA/N x DBA/2)F1 male mice and normal (DBA/2 x CBA/N)F1 male mice to generate 2,4,6-trinitrophenyl (TNP)-specific plaque-forming cell responses to TNP-keyhole limpet hemocyanin (KLH), TNP-conjugated Ficoll (TNP-Ficoll), TNP-Brucella abortus (BA), and TNP-lipopolysaccharide (LPS). The reciprocal F1 combinations used in this study differ genetically only in the origin of their X chromosome, but differ immunologically in that (CBA/N x DBA/2)F1 male mice express all the CBA/N immune abnormalities, whereas (DBA/2 x CBA/N)F1 male mice are immunologically normal. Analysis of thymic-dependent responses to TNP-KLH revealed that abnormal F1 mice were capable of generating primary responses in vivo to high doses of TNP-KLH, but failed to generate responses to suboptimal doses of TNP-KLH that were still immunogenic for normal F1 mice. Furthermore, under limiting in vitro micro-culture conditions, the abnormal F1 mice failed to generate primary thymic-dependent responses to any dose of TNP-KLH, even though under the identical conditions normal F1 mice consistently responded to a wide antigen dose range. The cellular basis of the failure of abnormal F1 mice to respond in vitro to TNP-KLH was investigated by assaying the ability of purified populations of accessory cells, T cells, and B cells from these mice to function in responses to TNP-KLH. The results of these experiments demonstrated that helper T cells and antigen-presenting accessory cells from abnormal F1 mice were competent and functioned as well as the equivalent cell populations from normal F1 mice. Instead, the failure of CBA/N mice to generate primary in vitro responses to TNP-KLH was solely the result of a defect in their B cell population such that B cells from these mice failed to be triggered by competent helper T cells and/or competent accessory cells. Similarly, the failure of abnormal F1 mice to respond either in vivo or in vitro to TNP-Ficoll was not the result of defective accessory cell presentation of TNP-Ficoll, but was the result of the failure of B cells from these mice to be activated by competent TNP-Ficoll-presenting accessory cells. In contrast to the failure of B cells from abnormal F1 mice to be activated in vitro in response to either TNP-KLH or TNP-Ficoll, B cells from abnormal F1 mice were triggered to respond to TNP-BA and TNP-LPS, antigens that did not require accessory cell presentation. The specific failure of B cells fron abnormal F1 mice to be activated in responses that required antigen-presentation by accessory cells suggested the possibility that the X-linked CBA/N genetic defect resulted in B cell populations that might be deficient in their ability to interact with antigen-presenting accessory cells...

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6159444      PMCID: PMC2186008          DOI: 10.1084/jem.152.5.1194

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  B-lymphocyte heterogeneity: development and characterization of an alloantiserum which distinguishes B-lymphocyte differentiation alloantigens.

Authors:  A Ahmed; I Scher; S O Sharrow; A H Smith; W E Paul; D H Sachs; K W Sell
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

2.  X-linked B lymphocyte defect in CBA/N mice. IV. Cellular and environmental influences on the thymus dependent IgG anti-sheep red blood cell response.

Authors:  I Scher; A K Berning; R Asofsky
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

3.  The ontogeny of thymic independent antibody responses in vitro in normal mice and mice with an X-linked B cell defect.

Authors:  D E Mosier; J J Mond; E A Goldings
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

4.  Cellular and genetic control of antibody responses in vitro. I. Cellular requirements for the generation of genetically controlled primary IgM responses to soluble antigens.

Authors:  R J Hodes; A Singer
Journal:  Eur J Immunol       Date:  1977-12       Impact factor: 5.532

5.  Role of accessory cells in B cell activation. II. The interaction of B cells with accessory cells results in the exclusive activation of an Lyb5+ B cell subpopulation.

Authors:  H S Boswell; A Ahmed; I Scher; A Singer
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

6.  A B cell subpopulation binds to macrophages: this binding can be disrupted by T cells.

Authors:  M M O'Toole; H H Wortis
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

7.  Cellular and genetic control of antibody responses in vitro. III. Immune response gene regulation of accessory cell function.

Authors:  A Singer; C Cowing; K S Hathcock; H B Dickler; R J Hodes
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

8.  Plaque Formation in Agar by Single Antibody-Producing Cells.

Authors:  N K Jerne; A A Nordin
Journal:  Science       Date:  1963-04-26       Impact factor: 47.728

9.  X-linked B-lymphocyte immune defect in CBA/N mice. II. Studies of the mechanisms underlying the immune defect.

Authors:  I Scher; A D Steinberg; A K Berning; W E Paul
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

10.  Cellular and genetic control of antibody responses. V. Helper T-cell recognition of H-2 determinants on accessory cells but not B cells.

Authors:  A Singer; K S Hathcock; R J Hodes
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

View more
  14 in total

1.  Induction of in vivo antipolysaccharide immunoglobulin responses to intact Streptococcus pneumoniae is more heavily dependent on Btk-mediated B-cell receptor signaling than antiprotein responses.

Authors:  Abdul Q Khan; Goutam Sen; Shuling Guo; Owen N Witte; Clifford M Snapper
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

2.  Btk dosage determines sensitivity to B cell antigen receptor cross-linking.

Authors:  A B Satterthwaite; H Cheroutre; W N Khan; P Sideras; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

3.  Deficiency of regulatory B cells increases allergic airway inflammation.

Authors:  S K Lundy; A A Berlin; T F Martens; N W Lukacs
Journal:  Inflamm Res       Date:  2005-12       Impact factor: 4.575

4.  Macrophage-lymphocyte interaction in response to a bacterial antigen (E. coli).

Authors:  M Eibl; J W Mannhalter; R Ahmad
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

5.  Btk regulates B cell receptor-mediated antigen processing and presentation by controlling actin cytoskeleton dynamics in B cells.

Authors:  Shruti Sharma; Gregory Orlowski; Wenxia Song
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

6.  Bruton's Tyrosine Kinase Is Not Essential for B Cell Survival beyond Early Developmental Stages.

Authors:  Lindsay E Nyhoff; Emily S Clark; Bridgette L Barron; Rachel H Bonami; Wasif N Khan; Peggy L Kendall
Journal:  J Immunol       Date:  2018-02-26       Impact factor: 5.422

7.  Antigen recognition. V. Requirement for histocompatibility between antigen-presenting cell and B cell in the response to a thymus-dependent antigen, and lack of allogeneic restriction between T and B cells.

Authors:  E Nisbet-Brown; B Singh; E Diener
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

8.  Antigen-specific, H-2-restricted helper T cell hybridomas.

Authors:  N W Roehm; P Marrack; J W Kappler
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307

9.  Role of the major histocompatibility complex in T cell activation of B cell subpopulations Lyb-5+ and Lyb-5- B cell subpopulations differ in their requirement for major histocompatibility complex-restricted T cell recognition.

Authors:  A Singer; P J Morrissey; K S Hathcock; A Ahmed; I Scher; R J Hodes
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

10.  Next-generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells.

Authors:  Eris Bame; Hao Tang; Jeremy C Burns; Million Arefayene; Klaus Michelsen; Bin Ma; Isaac Marx; Robin Prince; Allie M Roach; Urjana Poreci; Douglas Donaldson; Patrick Cullen; Fergal Casey; Jing Zhu; Thomas M Carlile; Dipen Sangurdekar; Baohong Zhang; Patrick Trapa; Joseph Santoro; Param Muragan; Alex Pellerin; Stephen Rubino; Davide Gianni; Bekim Bajrami; Xiaomei Peng; Alex Coppell; Katherine Riester; Shibeshih Belachew; Devangi Mehta; Mike Palte; Brian T Hopkins; Matthew Scaramozza; Nathalie Franchimont; Michael Mingueneau
Journal:  Clin Transl Immunology       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.